G
George Jour
Researcher at New York University
Publications - 93
Citations - 1713
George Jour is an academic researcher from New York University. The author has contributed to research in topics: Medicine & Gene. The author has an hindex of 17, co-authored 79 publications receiving 1053 citations. Previous affiliations of George Jour include Mount Sinai St. Luke's and Mount Sinai Roosevelt & Columbia University.
Papers
More filters
Journal ArticleDOI
Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients with Outcome and Symptoms.
Kimon V. Argyropoulos,Antonio Serrano,Jiyuan Hu,Margaret Black,Xiaojun Feng,Guomiao Shen,Melissa Call,Min Jae Kim,Andrew Lytle,Brendan Belovarac,Theodore Vougiouklakis,Lawrence Hsu Lin,Una Moran,Adriana Heguy,Andrea B. Troxel,Matija Snuderl,Iman Osman,Paolo Cotzia,George Jour +18 more
TL;DR: The findings suggest a higher shedding risk in less symptomatic patients, an important consideration for containment strategies, and identify a novel association between VL and history of cancer.
Journal ArticleDOI
Validation of the Risk Model: High-Risk Classification and Tumor Pattern of Invasion Predict Outcome for Patients with Low-Stage Oral Cavity Squamous Cell Carcinoma
Yufeng Li,Shuting Bai,William R. Carroll,Dan Dayan,Joseph C. Dort,Keith S. Heller,George Jour,Harold Lau,Carla Penner,Michael B. Prystowsky,Eben L. Rosenthal,Nicolas F. Schlecht,Richard V. Smith,Mark L. Urken,Marilena Vered,Beverly Y. Wang,Bruce M. Wenig,Abdissa Negassa,Margaret Brandwein-Gensler +18 more
TL;DR: The hypothesis that the Risk Model has added prognostic value for low-stage oral cavity squamous cell carcinoma (OCSCC) patients is tested and it is shown that this model may potentially shift treatment paradigms for patients with low- stage cancers.
Journal ArticleDOI
Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions
George Jour,Isabella C. Glitza,Rachel M. Ellis,Carlos A. Torres-Cabala,Michael T. Tetzlaff,Janet Y. Li,Priyadharsini Nagarajan,Auris Huen,Phyu P. Aung,Doina Ivan,Carol R. Drucker,Victor G. Prieto,Ronald P. Rapini,Ronald P. Rapini,Anisha B. Patel,Anisha B. Patel,Jonathan L. Curry +16 more
TL;DR: The experience with five patients who presented with pruritic vesicles and blisters on the skin while treated with anti‐PD‐1 antibody immunotherapy with either nivolumab or pembrolizumab is reported.
Journal ArticleDOI
Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region.
Matthew T. Maurano,Sitharam Ramaswami,Paul Zappile,Dacia Dimartino,Ludovic Boytard,André M. Ribeiro-dos-Santos,Nicholas A. Vulpescu,Gael Westby,Guomiao Shen,Xiaojun Feng,Megan S. Hogan,Manon Ragonnet-Cronin,Lily Geidelberg,Christian Marier,Peter Meyn,Yutong Zhang,John Cadley,Raquel Ordoñez,Raven Luther,Emily P. Huang,Emily Guzman,Carolina Arguelles-Grande,Kimon V. Argyropoulos,Margaret Black,Antonio Serrano,Melissa Call,Min Jae Kim,Brendan Belovarac,Tatyana Gindin,Andrew Lytle,Jared Pinnell,Theodore Vougiouklakis,John J. Chen,Lawrence Hsu Lin,Amy Rapkiewicz,Vanessa Raabe,Marie I. Samanovic,George Jour,Iman Osman,Maria E Aguero-Rosenfeld,Mark J. Mulligan,Erik M. Volz,Paolo Cotzia,Matija Snuderl,Adriana Heguy +44 more
TL;DR: Analysis of 864 SARS-CoV-2 sequences from cases in the New York City metropolitan area during the COVID-19 outbreak in spring 2020 showed that early transmission was most linked to cases from Europe.
Journal ArticleDOI
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome.
Imran Sulaiman,Matthew Chung,Luis Angel,Jun-Chieh J. Tsay,Benjamin G. Wu,Stephen T. Yeung,Kelsey Krolikowski,Yonghua Li,Ralf Duerr,R. Schluger,Sara A Thannickal,Akiko Koide,Samaan Rafeq,Clea Barnett,Radu Postelnicu,Chang Wang,Stephanie Banakis,Lizzette Pérez-Pérez,Guomiao Shen,George Jour,Peter Meyn,J. Carpenito,Xiuxiu Liu,Xiuxiu Liu,Kun Ji,Kun Ji,Destiny Collazo,Anthony Labarbiera,Nancy Amoroso,Shari B. Brosnahan,Vikramjit Mukherjee,David Kaufman,Jan Bakker,Anthony Lubinsky,Deepak Pradhan,Daniel H. Sterman,Michael D. Weiden,Adriana Heguy,Laura Evans,Timothy M. Uyeki,Jose C. Clemente,Emmie de Wit,Ann Marie Schmidt,Bo Shopsin,Ludovic Desvignes,Chan Wang,Huilin Li,Bin Zhang,Christian V. Forst,Shohei Koide,Kenneth A. Stapleford,Kamal M. Khanna,Elodie Ghedin,Elodie Ghedin,Leopoldo N. Segal +54 more
TL;DR: In this paper, the authors investigated whether bacterial respiratory infections were associated with poor clinical outcome of COVID-19 in a prospective, observational cohort of 589 critically ill adults, all of whom required mechanical ventilation.